首页> 美国卫生研究院文献>Oxford Open >1023. A Controlled-Release Prescription Oral Opioid Can Prolong S. aureus Survival in Injection Drug Preparation Equipment and Potentially Increase Bacteremia Risk
【2h】

1023. A Controlled-Release Prescription Oral Opioid Can Prolong S. aureus Survival in Injection Drug Preparation Equipment and Potentially Increase Bacteremia Risk

机译:1023.口服阿片类药物的控释处方可以延长金黄色葡萄球菌在注射药物制备设备中的存活并可能增加细菌血症的风险

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background S. aureus is the most common pathogen associated with injection drug use-associated endocarditis (IDUaIE). Our center has a high incidence of IDUaIE and the opiate of choice in our population is hydromorphone-controlled release (HCR), a prescribed oral opiate widely used in Canada and Europe. The complex technique for preparation for injection provides multiple opportunities for contamination of the solution and the controlled-release preparation contains several excipients (carbohydrates, protein, and iron), which could enhance Staphylococcal survival. A large amount of drug remains in the injection drug preparation equipment (IDPE) after each use and therefore, used IDPE is saved by people who inject drugs (PWID) for subsequent reuse by adding more water and then injecting the solution intravenously.
机译:背景金黄色葡萄球菌是与注射药物使用相关的心内膜炎(IDUaIE)相关的最常见病原体。我们中心的IDUaIE发生率很高,在我们的人群中选择的鸦片制剂是氢吗啡酮控释(HCR),这是一种在加拿大和欧洲广泛使用的处方口服鸦片制剂。注射制剂的复杂技术为溶液的污染提供了多种机会,而控释制剂中含有多种赋形剂(碳水化合物,蛋白质和铁),可以提高葡萄球菌的存活率。每次使用后,大量药物会留在注射药物制备设备(IDPE)中,因此,注射药物(PWID)的人可以节省用过的IDPE,以备后用,方法是添加更多的水,然后静脉内注射溶液。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号